APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Pain Patch

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-opioid Pain Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchNon-opioid Pain Patch Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Pain Patch Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Non-opioid Pain Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Pain Patch Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Pain Patch Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Non-opioid Pain Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-opioid Pain Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-opioid Pain Patch include Sanofi, Johnson & Johnson, Qizheng, Novartis, Mylan, Lingrui, Huarun 999, GSK and Teikoku Seiyaku, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-opioid Pain Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-opioid Pain Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-opioid Pain Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-opioid Pain Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-opioid Pain Patch Segment by Company

Sanofi

Johnson & Johnson

Qizheng

Novartis

Mylan

Lingrui

Huarun 999

GSK

Teikoku Seiyaku

Nichiban

Mentholatum

Laboratoires Genevrier

Hisamitsu

Haw Par

Endo

BLUE-EMU

Actavis

Non-opioid Pain Patch Segment by Type

Fentanyl Patches

Counter-Irritant Patches

Lidocaine Patches

Diclofenac Patches

Indomethacin Patches

Others

Non-opioid Pain Patch Segment by Application

OTC

Rx

Non-opioid Pain Patch Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Pain Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Pain Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Pain Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-opioid Pain Patch market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-opioid Pain Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-opioid Pain Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-opioid Pain Patch Industry Trends Table 2. Non-opioid Pain Patch Industry Drivers Table 3. Non-opioid Pain Patch Industry Opportunities and Challenges Table 4. Non-opioid Pain Patch Industry Restraints Table 5. Global Non-opioid Pain Patch Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-opioid Pain Patch Sales by Manufacturers (M Pcs) & (2021-2026) Table 8. Global Non-opioid Pain Patch Sales Market Share by Manufacturers Table 9. Global Non-opioid Pain Patch Average Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 10. Global Non-opioid Pain Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-opioid Pain Patch Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-opioid Pain Patch Manufacturers, Product Type & Application Table 13. Global Non-opioid Pain Patch Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-opioid Pain Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Fentanyl Patches Table 17. Major Manufacturers of Counter-Irritant Patches Table 18. Major Manufacturers of Lidocaine Patches Table 19. Major Manufacturers of Diclofenac Patches Table 20. Major Manufacturers of Indomethacin Patches Table 21. Major Manufacturers of Others Table 22. Global Non-opioid Pain Patch Sales by Type 2021 VS 2025 VS 2032 (M Pcs) Table 23. Global Non-opioid Pain Patch Sales by Type (2021-2026) & (M Pcs) Table 24. Global Non-opioid Pain Patch Sales by Type (2027-2032) & (M Pcs) Table 25. Global Non-opioid Pain Patch Sales Market Share by Type (2021-2026) Table 26. Global Non-opioid Pain Patch Sales Market Share by Type (2027-2032) Table 27. Global Non-opioid Pain Patch Revenue by Type 2021 VS 2025 VS 2032 (M Pcs) Table 28. Global Non-opioid Pain Patch Revenue by Type (2021-2026) & (M Pcs) Table 29. Global Non-opioid Pain Patch Revenue by Type (2027-2032) & (M Pcs) Table 30. Global Non-opioid Pain Patch Revenue Market Share by Type (2021-2026) Table 31. Global Non-opioid Pain Patch Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of OTC Table 33. Major Manufacturers of Rx Table 34. Global Non-opioid Pain Patch Sales by Application 2021 VS 2025 VS 2032 (M Pcs) Table 35. Global Non-opioid Pain Patch Sales by Application (2021-2026) & (M Pcs) Table 36. Global Non-opioid Pain Patch Sales by Application (2027-2032) & (M Pcs) Table 37. Global Non-opioid Pain Patch Sales Market Share by Application (2021-2026) Table 38. Global Non-opioid Pain Patch Sales Market Share by Application (2027-2032) Table 39. Global Non-opioid Pain Patch Revenue by Application 2021 VS 2025 VS 2032 (M Pcs) Table 40. Global Non-opioid Pain Patch Revenue by Application (2021-2026) & (M Pcs) Table 41. Global Non-opioid Pain Patch Revenue by Application (2027-2032) & (M Pcs) Table 42. Global Non-opioid Pain Patch Revenue Market Share by Application (2021-2026) Table 43. Global Non-opioid Pain Patch Revenue Market Share by Application (2027-2032) Table 44. Global Non-opioid Pain Patch Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 45. Global Non-opioid Pain Patch Sales by Region (2021-2026) & (M Pcs) Table 46. Global Non-opioid Pain Patch Sales Market Share by Region (2021-2026) Table 47. Global Non-opioid Pain Patch Sales Forecasted by Region (2027-2032) & (M Pcs) Table 48. Global Non-opioid Pain Patch Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 50. North America Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 51. North America Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 52. Europe Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 53. Europe Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 54. Europe Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 55. Asia Pacific Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 56. Asia Pacific Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 57. Asia Pacific Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 58. South America, Middle East and Africa Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 59. South America, Middle East and Africa Non-opioid Pain Patch Sales by Country (2021-2026) & (M Pcs) Table 60. South America, Middle East and Africa Non-opioid Pain Patch Sales by Country (2027-2032) & (M Pcs) Table 61. Global Non-opioid Pain Patch Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Non-opioid Pain Patch Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Non-opioid Pain Patch Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Non-opioid Pain Patch Revenue Market Share by Region (2021-2026) Table 65. Global Non-opioid Pain Patch Revenue Market Share by Region (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sanofi Non-opioid Pain Patch Product Portfolio Table 70. Sanofi Recent Development Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Non-opioid Pain Patch Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Qizheng Company Information Table 77. Qizheng Business Overview Table 78. Qizheng Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Qizheng Non-opioid Pain Patch Product Portfolio Table 80. Qizheng Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Novartis Non-opioid Pain Patch Product Portfolio Table 85. Novartis Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Mylan Non-opioid Pain Patch Product Portfolio Table 90. Mylan Recent Development Table 91. Lingrui Company Information Table 92. Lingrui Business Overview Table 93. Lingrui Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Lingrui Non-opioid Pain Patch Product Portfolio Table 95. Lingrui Recent Development Table 96. Huarun 999 Company Information Table 97. Huarun 999 Business Overview Table 98. Huarun 999 Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Huarun 999 Non-opioid Pain Patch Product Portfolio Table 100. Huarun 999 Recent Development Table 101. GSK Company Information Table 102. GSK Business Overview Table 103. GSK Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. GSK Non-opioid Pain Patch Product Portfolio Table 105. GSK Recent Development Table 106. Teikoku Seiyaku Company Information Table 107. Teikoku Seiyaku Business Overview Table 108. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio Table 110. Teikoku Seiyaku Recent Development Table 111. Nichiban Company Information Table 112. Nichiban Business Overview Table 113. Nichiban Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Nichiban Non-opioid Pain Patch Product Portfolio Table 115. Nichiban Recent Development Table 116. Mentholatum Company Information Table 117. Mentholatum Business Overview Table 118. Mentholatum Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Mentholatum Non-opioid Pain Patch Product Portfolio Table 120. Mentholatum Recent Development Table 121. Laboratoires Genevrier Company Information Table 122. Laboratoires Genevrier Business Overview Table 123. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio Table 125. Laboratoires Genevrier Recent Development Table 126. Hisamitsu Company Information Table 127. Hisamitsu Business Overview Table 128. Hisamitsu Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Hisamitsu Non-opioid Pain Patch Product Portfolio Table 130. Hisamitsu Recent Development Table 131. Haw Par Company Information Table 132. Haw Par Business Overview Table 133. Haw Par Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Haw Par Non-opioid Pain Patch Product Portfolio Table 135. Haw Par Recent Development Table 136. Endo Company Information Table 137. Endo Business Overview Table 138. Endo Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Endo Non-opioid Pain Patch Product Portfolio Table 140. Endo Recent Development Table 141. BLUE-EMU Company Information Table 142. BLUE-EMU Business Overview Table 143. BLUE-EMU Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. BLUE-EMU Non-opioid Pain Patch Product Portfolio Table 145. BLUE-EMU Recent Development Table 146. Actavis Company Information Table 147. Actavis Business Overview Table 148. Actavis Non-opioid Pain Patch Sales (M Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Actavis Non-opioid Pain Patch Product Portfolio Table 150. Actavis Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Non-opioid Pain Patch Distributors List Table 154. Non-opioid Pain Patch Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Non-opioid Pain Patch Product Image Figure 2. Global Non-opioid Pain Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Pain Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-opioid Pain Patch Sales (2021-2032) & (M Pcs) Figure 5. Global Non-opioid Pain Patch Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Non-opioid Pain Patch Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Fentanyl Patches Image Figure 9. Counter-Irritant Patches Image Figure 10. Lidocaine Patches Image Figure 11. Diclofenac Patches Image Figure 12. Indomethacin Patches Image Figure 13. Others Image Figure 14. Global Non-opioid Pain Patch Sales by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 15. Global Non-opioid Pain Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Non-opioid Pain Patch Sales Market Share by Type (2021-2032) Figure 17. Global Non-opioid Pain Patch Revenue by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 18. Global Non-opioid Pain Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Non-opioid Pain Patch Revenue Market Share by Type (2021-2032) Figure 20. OTC Image Figure 21. Rx Image Figure 22. Global Non-opioid Pain Patch Sales by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 23. Global Non-opioid Pain Patch Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Non-opioid Pain Patch Sales Market Share by Application (2021-2032) Figure 25. Global Non-opioid Pain Patch Revenue by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 26. Global Non-opioid Pain Patch Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Non-opioid Pain Patch Revenue Market Share by Application (2021-2032) Figure 28. North America Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 29. North America Non-opioid Pain Patch Sales Market Share by Country (2021-2032) Figure 30. U.S. Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 31. Canada Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 32. Mexico Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 33. Europe Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 34. Europe Non-opioid Pain Patch Sales Market Share by Country (2021-2032) Figure 35. Germany Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 36. France Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 37. U.K. Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 38. Italy Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 39. Netherlands Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 40. Asia Pacific Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 41. Asia Pacific Non-opioid Pain Patch Sales Market Share by Country (2021-2032) Figure 42. China Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 43. Japan Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 44. South Korea Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 45. Southeast Asia Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 46. India Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 47. Australia Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 48. South America, Middle East and Africa Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 49. South America, Middle East and Africa Non-opioid Pain Patch Sales Market Share by Country (2021-2032) Figure 50. Brazil Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 51. South Africa Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 52. Saudi Arabia Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 53. Turkey Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 54. Argentina Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 55. UAE Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 56. Egypt Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 57. Chile Non-opioid Pain Patch Sales and Growth Rate (2021-2032) & (M Pcs) Figure 58. Global Non-opioid Pain Patch Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Non-opioid Pain Patch Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Figure 61. North America Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Figure 63. Europe Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Non-opioid Pain Patch Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Non-opioid Pain Patch Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Non-opioid Pain Patch Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl Patches
  • Counter-Irritant Patches
  • Lidocaine Patches
  • Diclofenac Patches
  • Indomethacin Patches
  • Others
Applications
  • OTC
  • Rx
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Qizheng
  • Novartis
  • Mylan
  • Lingrui
  • Huarun 999
  • GSK
  • Teikoku Seiyaku
  • Nichiban
  • Mentholatum
  • Laboratoires Genevrier
  • Hisamitsu
  • Haw Par
  • Endo
  • BLUE-EMU
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-opioid Pain Patch Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-opioid Pain Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-opioid Pain Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-opioid Pain Patch Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-opioid Pain Patch Market Dynamics
  1. 2.1 Non-opioid Pain Patch Industry Trends
  2. 2.2 Non-opioid Pain Patch Industry Drivers
  3. 2.3 Non-opioid Pain Patch Industry Opportunities and Challenges
  4. 2.4 Non-opioid Pain Patch Industry Restraints
3 Non-opioid Pain Patch Market by Manufacturers
  1. 3.1 Global Non-opioid Pain Patch Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-opioid Pain Patch Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-opioid Pain Patch Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-opioid Pain Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-opioid Pain Patch Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-opioid Pain Patch Manufacturers, Product Type & Application
  7. 3.7 Global Non-opioid Pain Patch Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-opioid Pain Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-opioid Pain Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-opioid Pain Patch Tier 1, Tier 2, and Tier 3
4 Non-opioid Pain Patch Market by Type
  1. 4.1 Non-opioid Pain Patch Type Introduction
  2. 4.1.1 Fentanyl Patches
  3. 4.1.2 Counter-Irritant Patches
  4. 4.1.3 Lidocaine Patches
  5. 4.1.4 Diclofenac Patches
  6. 4.1.5 Indomethacin Patches
  7. 4.1.6 Others
  8. 4.2 Global Non-opioid Pain Patch Sales by Type
  9. 4.2.1 Global Non-opioid Pain Patch Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Non-opioid Pain Patch Sales by Type (2021-2032)
  11. 4.2.3 Global Non-opioid Pain Patch Sales Market Share by Type (2021-2032)
  12. 4.3 Global Non-opioid Pain Patch Revenue by Type
  13. 4.3.1 Global Non-opioid Pain Patch Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Non-opioid Pain Patch Revenue by Type (2021-2032)
  15. 4.3.3 Global Non-opioid Pain Patch Revenue Market Share by Type (2021-2032)
5 Non-opioid Pain Patch Market by Application
  1. 5.1 Non-opioid Pain Patch Application Introduction
  2. 5.1.1 OTC
  3. 5.1.2 Rx
  4. 5.2 Global Non-opioid Pain Patch Sales by Application
  5. 5.2.1 Global Non-opioid Pain Patch Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-opioid Pain Patch Sales by Application (2021-2032)
  7. 5.2.3 Global Non-opioid Pain Patch Sales Market Share by Application (2021-2032)
  8. 5.3 Global Non-opioid Pain Patch Revenue by Application
  9. 5.3.1 Global Non-opioid Pain Patch Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non-opioid Pain Patch Revenue by Application (2021-2032)
  11. 5.3.3 Global Non-opioid Pain Patch Revenue Market Share by Application (2021-2032)
6 Global Non-opioid Pain Patch Sales by Region
  1. 6.1 Global Non-opioid Pain Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-opioid Pain Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Non-opioid Pain Patch Sales by Region (2021-2026)
  4. 6.2.2 Global Non-opioid Pain Patch Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-opioid Pain Patch Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-opioid Pain Patch Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-opioid Pain Patch Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-opioid Pain Patch Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-opioid Pain Patch Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-opioid Pain Patch Revenue by Region
  1. 7.1 Global Non-opioid Pain Patch Revenue by Region
  2. 7.1.1 Global Non-opioid Pain Patch Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-opioid Pain Patch Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-opioid Pain Patch Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-opioid Pain Patch Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-opioid Pain Patch Revenue (2021-2032)
  8. 7.2.2 North America Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-opioid Pain Patch Revenue (2021-2032)
  11. 7.3.2 Europe Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-opioid Pain Patch Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-opioid Pain Patch Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-opioid Pain Patch Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Non-opioid Pain Patch Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Qizheng
  14. 8.3.1 Qizheng Company Information
  15. 8.3.2 Qizheng Business Overview
  16. 8.3.3 Qizheng Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qizheng Non-opioid Pain Patch Product Portfolio
  18. 8.3.5 Qizheng Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Non-opioid Pain Patch Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Non-opioid Pain Patch Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Lingrui
  32. 8.6.1 Lingrui Company Information
  33. 8.6.2 Lingrui Business Overview
  34. 8.6.3 Lingrui Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lingrui Non-opioid Pain Patch Product Portfolio
  36. 8.6.5 Lingrui Recent Developments
  37. 8.7 Huarun 999
  38. 8.7.1 Huarun 999 Company Information
  39. 8.7.2 Huarun 999 Business Overview
  40. 8.7.3 Huarun 999 Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
  42. 8.7.5 Huarun 999 Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Non-opioid Pain Patch Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Teikoku Seiyaku
  50. 8.9.1 Teikoku Seiyaku Company Information
  51. 8.9.2 Teikoku Seiyaku Business Overview
  52. 8.9.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
  54. 8.9.5 Teikoku Seiyaku Recent Developments
  55. 8.10 Nichiban
  56. 8.10.1 Nichiban Company Information
  57. 8.10.2 Nichiban Business Overview
  58. 8.10.3 Nichiban Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nichiban Non-opioid Pain Patch Product Portfolio
  60. 8.10.5 Nichiban Recent Developments
  61. 8.11 Mentholatum
  62. 8.11.1 Mentholatum Company Information
  63. 8.11.2 Mentholatum Business Overview
  64. 8.11.3 Mentholatum Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mentholatum Non-opioid Pain Patch Product Portfolio
  66. 8.11.5 Mentholatum Recent Developments
  67. 8.12 Laboratoires Genevrier
  68. 8.12.1 Laboratoires Genevrier Company Information
  69. 8.12.2 Laboratoires Genevrier Business Overview
  70. 8.12.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
  72. 8.12.5 Laboratoires Genevrier Recent Developments
  73. 8.13 Hisamitsu
  74. 8.13.1 Hisamitsu Company Information
  75. 8.13.2 Hisamitsu Business Overview
  76. 8.13.3 Hisamitsu Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
  78. 8.13.5 Hisamitsu Recent Developments
  79. 8.14 Haw Par
  80. 8.14.1 Haw Par Company Information
  81. 8.14.2 Haw Par Business Overview
  82. 8.14.3 Haw Par Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Haw Par Non-opioid Pain Patch Product Portfolio
  84. 8.14.5 Haw Par Recent Developments
  85. 8.15 Endo
  86. 8.15.1 Endo Company Information
  87. 8.15.2 Endo Business Overview
  88. 8.15.3 Endo Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Endo Non-opioid Pain Patch Product Portfolio
  90. 8.15.5 Endo Recent Developments
  91. 8.16 BLUE-EMU
  92. 8.16.1 BLUE-EMU Company Information
  93. 8.16.2 BLUE-EMU Business Overview
  94. 8.16.3 BLUE-EMU Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
  96. 8.16.5 BLUE-EMU Recent Developments
  97. 8.17 Actavis
  98. 8.17.1 Actavis Company Information
  99. 8.17.2 Actavis Business Overview
  100. 8.17.3 Actavis Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Actavis Non-opioid Pain Patch Product Portfolio
  102. 8.17.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-opioid Pain Patch Value Chain Analysis
  2. 9.1.1 Non-opioid Pain Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-opioid Pain Patch Production Mode & Process
  6. 9.2 Non-opioid Pain Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-opioid Pain Patch Distributors
  9. 9.2.3 Non-opioid Pain Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst